Stocks · Health care · Pharmaceutical Preparations

Stoke Therapeutics, Inc.

STOK Clue Score65
United States Fiscal year ends December CIK 0001623526 Results filed 29 Oct 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
Edward M. MD Kaye
30 Dec 2024
CEO
Exercised, kept
35,000
$0.60
$21.00K
Arthur Tzianabos
13 Feb 2024
Director
Exercised, kept
31,739
$2.19
$69.51K
Edward M. MD Kaye
27 Mar 2023
CEO
Exercised, kept
20,000
$0.60
$12.00K
Stephen J Tulipano
2 Jun 2022
CFO
Exercised, kept
11,160
$4.48
$50.00K
Edward M. MD Kaye
25 May 2022
CEO
Exercised, kept
15,000
$0.60
$9.00K
Edward M. MD Kaye
30 Dec 2020
CEO
Exercised, kept
10,000
$0.60
$6.00K
Showing 250 of 267 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 276
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 13
Sales on a Rule 10b5-1 plan 75
Sales straight out of an exercise 96
Sales at will 77
Transactions with no price 0
Shares from compensation/vesting 53,171,597
Sales filed before the plan box existed 15
History held since 20 Jun 2019